OSI

Sanofi-Aventis Recognized for Workplace Efforts to Prevent Cancer

...ot State University, H. Lee Moffitt Cancer Center and Research Institute, The National Cancer Institute (NCI), Novartis, The Oncology Nursing Society, osi Pharmaceuticals, Pfizer, PhRMA, PPD, Quintiles Transnational, SAS Institute, The University of North Dakota, US Oncology, Valeant Pharmaceuticals, Van...

Addiction Treatment Will Help Make Health Reform Affordable, New Analysis Shows

...hose governments are accountable to their citizens. To achieve its mission, osi seeks to shape public policies that assure greater fairness in political, legal, and economic systems and safeguard fundamental rights. osi works in over 60 countries in Europe, Asia, Africa, Latin America, and the ...

New Poll Finds Most Americans Support Including Treatment for Drug and Alcohol Addiction in National Health Care Reform; All Demographics Report Personal Experience With the Disease

...diction treatment," said Diana Morris, Director of osi Baltimore. "There is tremendous momentum now to r...untable to their citizens. To achieve its mission, osi seeks to shape public policies that assure greater...economic systems and safeguard fundamental rights. osi works in over 60 countries in Europe, Asia, Africa...

Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer

...LC., Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ), osi Pharmaceuticals, Inc. (Nasdaq: OSIP ) and Roche ...nt, Clinical Development Oncology and Drug Safety, osi Pharmaceuticals. "We are pleased to collaborate w...'s website at www.onyx-pharm.com . About osi Pharmaceuticals ...

Cadus Reports First Quarter 2009 Results

...et loss per share for the first quarter of 2008 of $0.02. Revenues for the first quarter of 2009 and 2008 consisted solely of a licensing fee paid by osi Pharmaceuticals, Inc. for its non-exclusive license to Cadus' yeast technologies. As of March 31, 2009, Cadus had 13,144,040 shares outstanding. ...

Closing the Addiction Treatment Gap Initiative Highlights Opportunities for New 'Drug Czar'

...hose governments are accountable to their citizens. To achieve its mission, osi seeks to shape public policies that assure greater fairness in political, legal, and economic systems and safeguard fundamental rights. osi works in over 60 countries in Europe, Asia, Africa, Latin America, and the ...

Global War on Drugs Takes Devastating Toll on Human Lives, Advocates Say

...olitical declaration that could impact the lives of millions of people. The osi publication, which includes studies and testimonies reflecting conditions i...t us without any reason." Their stories are among many accounts in the osi report that vividly document the ways in which drug control practices viola...

Lilly Reports Fourth-Quarter and Full-Year 2008 Results

...h the acquisitions of ICOS ($303.5 million), Hypnion ($291.1 million) and Ivy Animal Health ($37.0 million), as well as the licensing arrangement with osi Pharmaceuticals ($25.0 million), which decreased earnings per share by $.58 in total. Full...

ECRFPlus Achieves Milestone Multimillion Dollar Enterprise Agreement With CRO and Launches e-CRF+(TM): a CTMS and EDC Web Platform With ECG Analysis and Cardiac Safety Module.

... multi-year enterprise agreement with specialty contract research organization (CRO) and ECG core lab Spacelabs Healthcare Clinical Trial Services, an osi Systems Company. Although complete terms of the agreement are not being disclosed, the estimated value including custom software development and integ...

Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook

...nd reagent management. * Abbott Molecular Development Agreement -- Abbott entered into an agreement with Genentech, Hoffmann-La Roche and osi Pharmaceuticals to develop a gene-based test to assess the clinical benefit of Tarceva (erlotinib). Under the agreement, Abbott will dev...

More>>

OSI in Biological Technology

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...hKline Plc., Immunomedics, Inc., Indevus Pharmaceuticals Inc., Novartis AG, osi Pharmaceuticals, Inc., Paladin Labs Inc., Pfizer Inc., Progenics Pharmaceut...us Pharmaceuticals Inc. (USA) II-95 Novartis AG (Switzerland) II-96 osi Pharmaceuticals, Inc. (USA) II-96 Paladin Labs Inc. (Canada) II-97 ...

Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

... over the period 2006 through 2015. Leading players operating in the marketplace include Amgen Inc, Novartis, AstraZeneca plc, Genentech, Roche, osi Pharmaceuticals, Pfizer, Bristol-Myers Squibb, Glaxo SmithKline, Wyeth, Onyx Pharmaceuticals Inc., Merck & Co. Inc, KAI Pharmaceuticals Inc, Celge...

2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession

...BioPharma, Reata Pharmaceuticals, Proteolix, Novalar Pharmaceuticals, Lexicon Pharmaceuticals, Orexigen Therapeutics, Targacept, Helsinn Therapeutics, osi Prosidion, NovaDel Pharma, Anacor Pharmaceuticals, Ceragenix, Millennium Pharmaceuticals (Takeda), Pharmasset, Oscient Pharmaceuticals, Cenomed Biosci...

Mylan Confirms Four First-to-File Challenges

... 2008, according to IMS Health. Mylan Pharmaceuticals Inc. was sued by osi Pharmaceuticals Inc., Pfizer Inc. and Genentech Inc. in the U.S. District C... 25 mg, 100 mg and 150 mg. Erlotinib HCl Tablets are the generic version of osi Pharmaceuticals' lung cancer treatment Tarceva(R) Tablets, which had approx...

Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies

...ty and a collaborative spirit remain essential characteristics for successful life sciences companies." In the past year, BioTrove partnered with osi Pharmaceuticals, the BloodCenter of Wisconsin, and Constellation Pharmaceuticals to assist research efforts with the company's innovative technologies...

Pipeline for Breast Cancer Therapies is Focus of New MedPredict Report

...(Fosamax, odanacatib, MK-0646), Myriad (BRCA1/BRCA2 Screening), Merck/Ariad (deforolimus), Novartis (Zometa, Femara, everolimus, patupilone, TAE-266), osi (OSI-906), Pfizer (Aromasin, Sutent, Tarceva, CP-751871), Pierre Fabre (Javlor), Roche/GSK (Boniva), Roche (Xeloda), Sanofi-Aventis (AVE-1642), Scheri...

Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare

...ttings where patients' ventilation may be compromised and at risk. About Spacelabs Healthcare Spacelabs Healthcare is a wholly owned subsidiary of osi Systems, Inc. (Nasdaq: OSIS ). Spacelabs Healthcare, Inc. is an international developer, manufacturer and distributor of medical equipment and servic...

Lilly Reports Solid Second-Quarter Results

... charges associated with ICOS, Hypnion, and Ivy acquisitions (2007) and in-licensing transactions with BioMS and TransPharma (2008) and osi (2007) .07 .58 Benefit from resolution of IRS audit in first quarter of 2008 (.19) - ...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...NYSE: GB ) HOSPIRA INC (NYSE: HSP ) KINETIC CONCEPTS INC (NYSE: KCI ) osi SYSTEMS INC (NASDAQ: OSIS ) PALL CORP (NYSE: PLL ) RTI BIOLOGICS INC (N...RPORATION (NASDAQ: MASI ) MEDA AB (OMX Nordic Exchange Stockholm: MEDAA) osi PHARMACEUTICALS INC (NASDAQ: OSIP ) SEPRACOR INC. (NASDAQ: SEPR ) SHIRE...

OrthoSynetics(TM) Goes Green

..., La., May 29 /PRNewswire/ -- OrthoSynetics(TM), the largest provider of business services to orthodontic and dental practices worldwide, has launched osi Goes Green!, an effort to encourage energy conservation at its corporate headquarters and the more than 300 practices it serves nationwide. "This ef...

More>>